Last 29.75 INR
Change Today -0.20 / -0.67%
Volume 39.0K
BFNA On Other Exchanges
Symbol
Exchange
BFNA is not on other exchanges.
As of 6:05 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

bafna pharmaceuticals ltd (BFNA) Snapshot

Open
29.50
Previous Close
29.95
Day High
31.50
Day Low
29.05
52 Week High
07/2/14 - 38.50
52 Week Low
04/1/14 - 16.55
Market Cap
555.0M
Average Volume 10 Days
49.3K
EPS TTM
0.76
Shares Outstanding
18.7M
EX-Date
09/19/13
P/E TM
39.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for BAFNA PHARMACEUTICALS LTD (BFNA)

Related News

No related news articles were found.

bafna pharmaceuticals ltd (BFNA) Related Businessweek News

No Related Businessweek News Found

bafna pharmaceuticals ltd (BFNA) Details

Bafna Pharmaceuticals Limited manufactures and sells medicines and drugs in India and internationally. The company offers Raricap for the treatment of iron deficiency anaemia; Raricap Forte for the treatment of iron deficiency anaemia in pregnancy and lactation; Raricap L Suspension for the treatment of iron deficiency anaemia in children; Raricap Combi for the treatment of iron deficiency anaemia and calcium deficiency during pregnancy and lactation; Raricap Drops for the treatment of iron deficiency and iron deficiency anaemia in infants and toddlers; Raricap M; and Raricap Maa. It also provides contract manufacturing services. The company was founded in 1981 and is based in Chennai, India.

677 Employees
Last Reported Date: 08/14/14
Founded in 1981

bafna pharmaceuticals ltd (BFNA) Top Compensated Officers

Chairman, Managing Director, Member of Audit ...
Total Annual Compensation: 1.2M
Whole Time Director and Member of Stakeholder...
Total Annual Compensation: 960.0K
Compensation as of Fiscal Year 2014.

bafna pharmaceuticals ltd (BFNA) Key Developments

Bafna Pharmaceuticals Limited Announces Unaudited Standalone Earnings Results for the Second Quarter and Half Year Ended September 30, 2014

Bafna Pharmaceuticals Limited announced unaudited standalone earnings results for the second quarter and half year ended September 30, 2014. For the quarter, the company reported net sales of INR 231.941 million against INR 469.927 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 423.777 million against INR 51.878 million a year ago. Profit from ordinary activities before tax was INR 362.751 million against INR 17.496 million a year ago. Net profit for the period was INR 332.193 million or INR 17.81 basic and diluted per share before and after extraordinary items against INR 11.867 million or INR 0.64 basic and diluted per share before and after extraordinary items a year ago. For the half year, the company reported net sales of INR 584.205 million against INR 915.305 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 460.199 million against INR 83.323 million a year ago. Profit from ordinary activities before tax was INR 366.951 million against INR 33.185 million a year ago. Net profit for the period was INR 335.287 million or INR 17.97 basic and diluted per share before and after extraordinary items against INR 22.406 million or INR 1.20 basic and diluted per share before and after extraordinary items a year ago.

Bafna Pharmaceuticals Limited to Report Q2, 2015 Results on Nov 07, 2014

Bafna Pharmaceuticals Limited announced that they will report Q2, 2015 results on Nov 07, 2014

Bafna Pharmaceuticals Limited, Board Meeting, Nov 07, 2014

Bafna Pharmaceuticals Limited, Board Meeting, Nov 07, 2014. Agenda: To review and recommend the unaudited standalone earnings results for the second quarter and six months ended September 30, 2014 by the audit committee and approved by the board of directors.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BFNA:IN 29.75 INR -0.20

BFNA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BFNA.
View Industry Companies
 

Industry Analysis

BFNA

Industry Average

Valuation BFNA Industry Range
Price/Earnings 31.9x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 4.3x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAFNA PHARMACEUTICALS LTD, please visit www.bafnapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.